tiprankstipranks
Trending News
More News >
Altimmune (ALT)
NASDAQ:ALT

Compare Altimmune (ALT) vs. Competitors

Compare
3,622 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Altimmune
$3.34
$434.43M
-3.61
-42.21%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.52
$33.02M
-16.53
-77.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$6.76
$352.04M
-9.89
31.52%
3 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$622.23M
-9.36
171.92%
2 Buy
1 Hold
0 Sell
Moderate Buy
enGene Holdings
$7.21
$482.99M
5.39
38.39%
6 Buy
1 Hold
0 Sell
Strong Buy
Lexeo Therapeutics, Inc.
$5.65
$412.38M
-4.99
110.04%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALT
Altimmune
3.34
-2.71
-44.79%
TVRD
Tvardi Therapeutics
3.52
-13.34
-79.12%
DMAC
Diamedica Therapeutics
6.76
1.81
36.57%
DRTS
Alpha Tau Medical Ltd
7.07
4.37
161.85%
ENGN
enGene Holdings
7.21
2.58
55.72%
LXEO
Lexeo Therapeutics, Inc.
5.65
1.56
38.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts